Loading stock data…
LFWD
$6.98+0.00 (+0.03%)
After Hours$7.30+0.32 (+4.55%)· Last close Jun 9
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Lifeward Ltd. in the Healthcare sector is trading at $6.98. Wall Street consensus targets $20.00 (2 analysts), implying a +186.4% move over the next 12 months. The stock is currently 53% below its 52-week high of $15.00, remaining 4.1% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +186.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$6.98
Potential Downside
0%
Whystock Fair Value$6.98
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus2 analysts
Mean target$20.00+186.4%
Range$10.00 – $30.00
Fundamentals
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Ger...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-179.35%
Volume
Today's trading volume
3,067
Recent News
How The Lifeward (LFWD) Story Is Shifting With New Price Targets And Valuation Assumptions
Lifeward’s analyst price target has shifted to US$10, prompting a closer look at what is driving this new reference point for the stock. Analysts link the change to updates in their fair value frameworks, which now align the US$10 target with revised assumptions around the company’s future financial profile. As you read on, you will see how this evolving narrative might shape your view of where Lifeward sits today and what to watch next. Analyst Price Targets don't always capture the full...
Lifeward Ltd (LFWD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth ...
Lifeward Ltd (LFWD) reports a revenue dip amid supply chain issues but strengthens its position with strategic acquisitions and financing.
Lifeward (LFWD) Q1 2026 Earnings Transcript
William Grant: Thank you, Almog, and thank you for everybody for joining us today. The first quarter of 2026 marked an important strategic milestone for Lifeward as we successfully completed the acquisition of Oratech.
Lifeward Ltd. Q1 2026 Earnings Call Summary
Moby summary of Lifeward Ltd.'s Q1 2026 earnings call
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
Lifeward (LFWD) delivered earnings and revenue surprises of -1,870.59% and -35.69%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?